ImPact Biotech receives FDA Orphan Drug Designation for Padeliporfin VTP in Pancreatic Cancer
Designation confers advantages including marketing exclusivity and tax credits Padeliporfin VTP Phase 1 trial in Pancreatic…
Year: 2023
ImPact Biotech receives FDA Orphan Drug Designation for Padeliporfin VTP in Pancreatic Cancer
Designation confers advantages including marketing exclusivity and tax credits Padeliporfin VTP Phase 1 trial in Pancreatic…
Oral Simufilam Slowed Cognitive Decline in a Randomized Withdrawal Trial of Mild-to-Moderate Alzheimer’s Disease
CHART 1 Decline in Cognition Scores, FAS CHART 2 Decline in Cognition Scores, patients with…
Oral Simufilam Slowed Cognitive Decline in a Randomized Withdrawal Trial of Mild-to-Moderate Alzheimer’s Disease
CHART 1 Decline in Cognition Scores, FAS CHART 2 Decline in Cognition Scores, patients with…
BlueSteel Cybersecurity Provides Risk Assessments for Key Industries Including Healthcare, Government Services, Fintech, Research, and Education
The cybersecurity firm is offering specialized risk assessments to help organizations in these crucial sectors…
Janus International Group Appoints Roger Fradin as Vice Chairman
TEMPLE, Ga.–(BUSINESS WIRE)–Janus International Group, Inc. (NYSE: JBI) (“Janus” or the “Company”), a leading provider…
20th Edition of Digital Transformation Summit, Singapore
Physical Conference on 14th of July SINGAPORE, July 5, 2023 – (ACN Newswire) – In…
Dogtainers and Dr. Harry: Discover the Fascinating World of Animal Transit
SYDNEY, AU, Jul 5, 2023 – (ACN Newswire) – Animals Aboard with Dr. Harry, a…
Altus Power, Inc. Announces Completion of 5 Megawatt Solar Array in New York
STAMFORD, Conn.–(BUSINESS WIRE)–Altus Power, Inc. (NYSE: AMPS), the premier independent developer, owner, and operator of…
Mayville Engineering Company Completes Acquisition of Mid-States Aluminum
MAYVILLE, Wis.–(BUSINESS WIRE)–Mayville Engineering Company, Inc. (NYSE: MEC) (the “Company” or “MEC”), a leading value-added…
Yext Releases Yext Content, The Headless CMS Built on a Foundation of AI
Yext leverages AI and knowledge graph technology to equip companies with a single content system…
Invitation Homes and Esusu to Provide Free Positive Credit Reporting For Nearly 200,000 Invitation Homes Residents
DALLAS & HARLEM, N.Y.–(BUSINESS WIRE)–Invitation Homes Inc. (NYSE: INVH) (“Invitation Homes” or the “Company”), the…
New Research From Utimaco Uncovers Vast Regional Disparities In Consumer Trust In Digital Security
Aachen, Germany, 5 July 2023 – Utimaco, a leading global provider of IT security solutions…
Scilex Holding Company Generates Record Monthly Revenue In June 2023 And Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The One Month Ended June 2023, Quarter Ended June 2023, And Year-To-Date As Of June 2023, Based On Currently Available Information
PALO ALTO, Calif., July 05, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”),…
Scilex Holding Company Generates Record Monthly Revenue In June 2023 And Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The One Month Ended June 2023, Quarter Ended June 2023, And Year-To-Date As Of June 2023, Based On Currently Available Information
PALO ALTO, Calif., July 05, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”),…
Lucy Scientific Discovery, Inc. Achieves Major Milestone with Successful Completion of its Acquisition of the Assets of Wesana Health
Company Forms Lucy Discoveries Holdings for Future Research and Development VANCOUVER, British Columbia, July 05,…
Lucy Scientific Discovery, Inc. Achieves Major Milestone with Successful Completion of its Acquisition of the Assets of Wesana Health
Company Forms Lucy Discoveries Holdings for Future Research and Development VANCOUVER, British Columbia, July 05,…
Sorrento Announces Positive Phase IIa Study Results of Abivertinib for the Treatment of Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL) and Its Plan for a Pivotal Phase III Study
Abivertinib is a novel Bruton’s tyrosine kinase (BTK) inhibitor that irreversibly targets BTK. BTK inhibitors…
Sorrento Announces Positive Phase IIa Study Results of Abivertinib for the Treatment of Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL) and Its Plan for a Pivotal Phase III Study
Abivertinib is a novel Bruton’s tyrosine kinase (BTK) inhibitor that irreversibly targets BTK. BTK inhibitors…
Altamira Therapeutics Announces Collaboration with Heqet Therapeutics on Nanoparticle-Delivered Non-Coding RNAs for Cardiac Regeneration
HAMILTON, BERMUDA , July 05, 2023 (GLOBE NEWSWIRE) — Heqet will test nanoparticles based on…